Status:

NOT_YET_RECRUITING

Nucleosome Monitoring Relevance for Outcome Prediction in Critically Ill Patients

Lead Sponsor:

Erasme University Hospital

Conditions:

Sepsis

Septic Shock

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this observational study is to evaluate whether whole blood H3.1 nucleosome levels can predict 30-day mortality in adult critically ill patients admitted to the ICU with conditions such as...

Detailed Description

The NuROPI study is a prospective, observational, non-interventional, monocentric study conducted in the Intensive Care Unit (ICU) of Erasme Hospital, Brussels. It aims to evaluate the association bet...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Admission to the intensive care unit (ICU) within the past 24 hours.
  • Patient must meet one of the following conditions:
  • Sepsis, defined according to SEPSIS-3 criteria.
  • Septic shock, defined according to SEPSIS-3 criteria.
  • Cardiogenic shock, classified as Stage C according to the Society for Cardiovascular Angiography and Interventions (SCAI).
  • Severe trauma requiring transfusion of four or more units of red blood cells within six hours.
  • Acute brain injury requiring invasive neuromonitoring.
  • Post-cardiac arrest with at least 15 minutes of no or low perfusion.
  • Severe acute pancreatitis requiring ICU-level care.
  • \- Presence of an arterial or central venous catheter to allow blood sampling.
  • Exclusion Criteria
  • Patient who has expressed opposition to participate.
  • Age younger than 18 years.
  • Imminent death with an expected survival of less than 24 hours.
  • Presence of therapeutic limitations (e.g., no indication for intubation).
  • Active cancer.
  • Absence of the required vascular access.
  • ICU admission longer than 24 hours prior to screening.
  • Readmission of a previously enrolled patient.

Exclusion

    Key Trial Info

    Start Date :

    October 1 2025

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 30 2027

    Estimated Enrollment :

    130 Patients enrolled

    Trial Details

    Trial ID

    NCT07184593

    Start Date

    October 1 2025

    End Date

    September 30 2027

    Last Update

    September 22 2025

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    Nucleosome Monitoring Relevance for Outcome Prediction in Critically Ill Patients | DecenTrialz